The UNC School of Medicine faculty were featured in various media outlets during the week of June 13, 2025. Notable mentions include Dr. Joan Perry’s comments on the representation of physicians by the AMA, published in STAT. Dr. Christopher Sayed discussed the genetics of Hidradenitis Suppurativa and its connection to hair growth cycles in Medscape.
Dr. Joshua Zeidner’s research on a drug combination for acute myeloid leukemia (AML) patients with specific genetic profiles was highlighted in Oncology and EurekAlert!. His work focuses on the safety and efficacy of Revumenib combined with Azacitidine/Venetoclax for older patients with NPM1/KMT2Ar AML.
Dr. Bill Goodnight was featured in Spectrum News for his involvement in a case where a North Carolina family overcame a rare condition during twin pregnancy, resulting in two healthy babies.
UNC Health was mentioned by CBS17 for a story about a Johnston County father who received a double lung transplant after beating cancer.
Dr. Laura Ferris contributed to Innovation & Entrepreneurs News with findings from FDA pivotal studies showing that DermaSensor has 96% sensitivity and significantly reduces missed skin cancer diagnoses by physicians.
Dr. Becky White received recognition from The Journal of Blacks in Higher Education for her Citation Award from the HIV Medical Association.
Finally, Dr. Norman Sharpless was featured in The Irish Times discussing potential advancements toward ending deadly blood cancers, while Joshua F. Zeidner’s study on Revumenib triplet regimens for newly diagnosed AML with NPM1/KMT2A alterations appeared in The ASCO Post.
